Lv2
130 积分 2022-04-26 加入
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study
1年前
已完结
Human relationships: an exploration of loneliness and touch
1年前
已完结
Expert consensus on the treat-to-target strategy for psoriasis with biological agents in China
1年前
已完结
Secukinumab re‐initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis
1年前
已完结
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial
1年前
已完结
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials
1年前
已完结
The emerging role of IL-23 in asthma and its clinical implications
2年前
已完结
The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation
2年前
已完结
Mechanisms of pathogenesis in allergic asthma: Role of interleukin-23
2年前
已完结
Definitions of Remission in Psoriasis: A Systematic Literature Review from the National Psoriasis Foundation
2年前
已完结
皖公网安备34019202002308
